Cargando…
A regulatory science viewpoint on botanical–drug interactions
There is a continued predisposition of concurrent use of drugs and botanical products. Consumers often self-administer botanical products without informing their health care providers. The perceived safety of botanical products with lack of knowledge of the interaction potential poses a challenge fo...
Autores principales: | Grimstein, Manuela, Huang, Shiew-Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taiwan Food and Drug Administration
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326881/ https://www.ncbi.nlm.nih.gov/pubmed/29703380 http://dx.doi.org/10.1016/j.jfda.2018.01.013 |
Ejemplares similares
-
Clinical Pharmacology Regulatory Sciences in Drug Development and Precision Medicine: Current Status and Emerging Trends
por: Liu, Qi, et al.
Publicado: (2021) -
History of botanical science
por: Browne, Janet
Publicado: (1982) -
Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations
por: Zhang, Xinyuan, et al.
Publicado: (2021) -
Pharmacogenetic Labeling of FDA-Approved Drugs: A Regulatory Retrospective
por: Drozda, Katarzyna, et al.
Publicado: (2018) -
National Seminar on “Regulatory and Quality Aspects of Herbal Drugs and Botanicals”
por: Ahmad, Sayeed
Publicado: (2015)